Anti-aging skin care composition capable of relieving emotion as well as preparation method and application of anti-aging skin care composition

Through the extraction and formulation of traditional Chinese medicine compositions, the problem of single ingredients of existing emotional skin care products is solved, and an anti-aging skin care composition that can effectively absorb through the skin and play a role at the nerve and skin levels is provided, which significantly improves anxiety and depression. Emotional and skin health.

CN118948696AInactive Publication Date: 2024-11-15XIAN TIANKANG BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411039889.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The active substances of existing emotional skin care products are single, and it is difficult to effectively calm the mind and anti-aging effects through transdermal absorption. The market lacks rich ingredients that can effectively regulate the nervous system and skin.

Method used

Using the theory of neutral taste and meridians in traditional Chinese medicine, combined with the combination of lotus germ, forsythia, cinnamon, light bamboo leaves, Ophiopogon japonicus, Yuanzhi and other traditional Chinese medicines, through extraction, purification and preparation, an anti-aging skin care combination that soothes the mood is prepared. Used in skin care products.

Benefits of technology

This composition can effectively protect the central and peripheral nervous systems, reduce anxiety and depression, improve skin health, promote collagen formation, regulate skin water and oil balance, reduce reactive oxygen damage, and significantly improve skin and neurological functions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948696A_ABST
    Figure CN118948696A_ABST
Patent Text Reader

Abstract

The invention provides an anti-aging skin care composition capable of relieving emotion as well as a preparation method and application of the anti-aging skin care composition, and belongs to the technical field of emotion skin care products. The composition comprises the following components in parts by weight: 10-30 parts of lotus germs, 10-30 parts of fructus forsythiae, 5-20 parts of cinnamon, 10-30 parts of lophatherum gracile, 5-20 parts of radix ophiopogonis and 5-20 parts of polygala tenuifolia. The composition disclosed by the invention is prepared according to the theory of traditional Chinese medicine, mainly enters the heart meridians to calm the heart and tranquilize the mind, and can effectively protect the central and peripheral nervous systems, reduce anxiety and depression and relieve the tension state of facial muscles; the composition has the effects of inhibiting bacteria and resisting inflammation, improving local blood circulation of skin and reducing red and swollen, papule and pruritus symptoms caused by infection and allergy of the skin; the skin active oxygen injury is relieved, the skin water-oil balance is regulated, the collagen formation is promoted, the elastin degradation is inhibited, and finally the emotion anti-aging effect is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of emotional skin care products, and in particular to an anti-aging skin care composition for soothing emotions, and a preparation method and application thereof. Background Art

[0002] The theory of emotions in traditional Chinese medicine believes that joy, anger, worry, thought, sadness, fear and shock are the physiological and psychological reactions of the human body to changes in the internal and external environment. Normal emotions can make the human body's qi and blood flow smoothly and promote the body's health, but excessive or insufficient emotions can damage the internal organs and deplete the essence. "Suwen·Jutonglun" says: "All diseases are caused by qi. Anger causes the qi to rise, joy causes the qi to slow down, sadness causes the qi to disappear, and fear causes the qi to fall." Poor circulation of qi and blood causes qi stagnation and blood stasis, making it impossible for the internal organs and essence to nourish the spirit, and the spirit cannot be kept inside, resulting in symptoms such as depression or irritability, and accelerating the aging of the human body. This is consistent with the view that negative emotions can lead to aging, which is generally accepted in modern medicine.

[0003] Aging is the degenerative changes in the whole body's morphological structure and physiological functions that occur as organisms age. It is a gradual process affected by genetic factors. Physiological aging is mainly manifested in two aspects. On the one hand, it is the decline and change of systemic functions of the body, such as decreased skin elasticity, wrinkles, pigmentation, etc., the decline of various body functions, and reduced sensitivity to touch, vision, hearing, and smell; on the other hand, it is the damage and aging of the nervous system, which is mainly manifested in decreased cognitive ability.

[0004] Modern research shows that psychological stress, mental tension, mood swings and other psychological stress are closely related to aging. This influence can be manifested in the human body at the level of biomolecules, such as dysregulated stress hormone response, increased levels of inflammatory factors and shortened telomeres. Under long-term psychological stress, the hypothalamus-pituitary-adrenal (HPA) axis of the human endocrine system will be persistently hyperactive, and the level of stress hormones in the human body will continue to increase, leading to central neuron damage, further triggering inflammation, autoimmunity, obesity and other related diseases. In addition, negative emotions can also shorten cell telomeres, thereby limiting the rate of cell proliferation and accelerating cell aging. People who are exposed to negative emotional stimulation for a long time often have poor cognitive and memory abilities. This aging caused by negative emotions is reflected in both the physical and neural levels, and there is a certain positive feedback regulation effect. In other words, aging caused by negative emotions will further accelerate the aging process through changes in the level of biomolecules. Therefore, regulating emotions, relieving psychological pressure and protecting the nervous system from damage is also an important way to prevent aging.

[0005] Currently, the main effective ingredients of emotional skin care cosmetics on the market are plant volatile oils, which are mainly presented in the form of aromatic essential oil products. They act on the human body through methods such as aromatherapy, using respiratory or transdermal absorption routes, while the active substances in volatile oil products are relatively single. Therefore, selecting active natural substances with richer structural types that have calming and soothing effects, and protecting the nervous system, and enabling them to effectively enter the human body through transdermal absorption routes to exert their effects, is an important area of ​​research on emotional skin care products in the future. Summary of the invention

[0006] The present invention provides a mood-relief anti-aging skin care composition, a preparation method and application thereof, which uses a combination of various Chinese medicines that enter the heart meridian according to the neutral taste and meridian theory of traditional Chinese medicine to relieve mood and provide anti-aging skin care, thereby solving the problems mentioned in the background technology.

[0007] The first aspect of the present invention provides a soothing anti-aging skin care composition, which comprises, by weight, 10-30 parts of lotus embryos, 10-30 parts of forsythia, 5-20 parts of cinnamon, 10-30 parts of loquat leaves, 5-20 parts of ophiopogon, and 5-20 parts of polygala.

[0008] Furthermore, the composition comprises, by weight: 10-25 parts of lotus embryo, 14-25 parts of forsythia, 6-15 parts of cinnamon bark, 10-20 parts of loquat leaf, 5-15 parts of ophiopogon japonicus, and 8-20 parts of polygala tenuifolia.

[0009] The second aspect of the present invention provides a method for preparing the mood-relief anti-aging skin care composition, comprising:

[0010] S1 extraction: extracting the raw material of the composition twice to obtain two extracts, which are then combined and concentrated under reduced pressure;

[0011] S2 purification: The concentrated solution was statically adsorbed on the resin for 24 hours, loaded into a column, eluted with pure water and then with 70% ethanol aqueous solution, and the 70% ethanol elution fraction was collected and concentrated;

[0012] Preparation of S3: Mix the obtained concentrated solution according to 10% of the concentrated solution, 55% of butanediol, 4% of propylene glycol, 6% of glycerol and 25% of water, stir at 60° C. for 30 minutes, and filter with a 0.22 μm filter membrane to obtain a composite product.

[0013] In S1, the raw materials of the composition were added with 71% ethanol aqueous solution at a liquid-to-material ratio of 16:1, the pH was adjusted to 5.0 with glacial acetic acid, and the mixture was heated under reflux for 256 minutes to obtain the first extract; 75% ethanol aqueous solution was added to the medicinal residues of the composition at a liquid-to-material ratio of 17:1, the pH was adjusted to 8.6 with aqueous ammonia, and the mixture was heated under reflux for 263 minutes to obtain the second extract; the two extracts were combined, concentrated under reduced pressure, and the ratio of concentrated solution (L): medicinal material (kg) was 1:2 to obtain a concentrated solution.

[0014] In S2, the resin is D101 macroporous adsorption resin, and the adsorption is carried out according to the ratio of the raw material to the resin of 1:1.25 (kg / L). After static adsorption for 24 hours, the column is loaded and eluted with pure water first, with a flow rate of 1BV / h and an elution volume of 7BV; then eluted with 70% ethanol aqueous solution, with a flow rate of 1.4BV / h and an elution volume of 13BV. The 70% ethanol elution portion is collected and concentrated. The amount of concentrate (L): medicinal material (kg): 1:5.

[0015] The third aspect of the present invention provides the soothing anti-aging skin care composition, which has the functions of protecting the central and peripheral nervous systems, reducing anxiety and depression; reducing the redness and swelling symptoms caused by skin infection and allergies; alleviating skin active oxygen damage, regulating the water and oil balance of the skin, and promoting the formation of collagen. It can be used as the main functional ingredient of skin care products, including but not limited to toners, essences, creams and facial masks.

[0016] The present invention adopts the above technical solution, which has the following beneficial effects:

[0017] The lotus embryo in the invention can clear the heart and calm the mind, connect the heart and kidney, and has the effects of anti-inflammatory, sedative, anti-oxidation and protection of the central nervous system; the forsythia can clear away heat and detoxify, disperse knots and reduce swelling, and has the effects of analgesia, antibacterial, anti-inflammatory, anti-nutrition, inhibition of elastase activity and protection of nerves; the cinnamon bark can replenish fire and yang, warm and dredge the meridians, and has the effects of analgesia, sedation, anti-inflammatory, anti-oxidation and anti-depression; the light bamboo leaf can clear away heat and relieve restlessness, and has the effects of analgesia, anti-oxidation, regulation of immunity and protection of neurons; the ophiopogon can nourish yin and produce body fluid, moisten the lungs and clear the heart, and has the effects of anti-inflammatory, anti-oxidation, regulation of immunity, improvement of epidermal hydration capacity, regulation of neurotransmitter balance and promotion of nerve damage repair; the polygala can calm the mind and improve intelligence, connect the heart and kidney, and has the effects of sedation, anti-depression, inhibition of nerve cell apoptosis, prevention of nerve cell damage and improvement of cognitive function.

[0018] The composition of the present invention is formulated according to the theory of traditional Chinese medicine, mainly enters the heart meridian, calms the mind and soothes the nerves, can effectively protect the central and peripheral nervous systems, reduce anxiety and depression, and relieve facial muscle tension; inhibits bacteria and inflammation, improves local blood circulation of the skin, and reduces redness, swelling, papules, and itching symptoms caused by infection and allergy; reduces skin active oxygen damage, regulates skin water and oil balance, promotes collagen formation, inhibits elastin degradation, and ultimately plays an emotional anti-aging role. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] The drawings described herein are used to provide a further understanding of the present invention, constitute a part of the present invention, and do not constitute an improper limitation of the present invention. In the drawings:

[0020] Figure 1 This is a graph showing the content of various substances in the elution part of ethanol aqueous solution of different concentrations, which is a study of the ethanol elution concentration in the purification process of Experimental Example 1 of this application;

[0021] Figure 2 This is a graph showing the content of various substances at different elution flow rates in the elution flow rate study of the purification process in Experimental Example 1 of this application;

[0022] Figure 3 This is a graph of the content of various substances at different elution volumes for the investigation of the amount of ethanol elution used in the purification process of Experimental Example 1 of this application;

[0023] Figure 4 This is a process flow chart for preparing the mood-relief anti-aging skin care composition of Experimental Example 1 of this application;

[0024] Figure 5 This is a bar chart comparing the experimental results of the sugar water preference experiment in Experimental Example 3 of this application;

[0025] Figure 6 This is a bar graph comparison of the movement paths of rats in the open field experiment in Experimental Example 3 of this application;

[0026] Figure 7 This is a bar graph comparing the movement speed of rats in the open field test in Experimental Example 3 of this application;

[0027] Figure 8 This is a bar chart comparing the latency of rats to eat in the novel environment inhibition feeding experiment in Experimental Example 3 of this application;

[0028] Fig. 9 This is a bar chart comparing the number of times rats entered the open arms in the elevated plus maze experiment in Experimental Example 3 of this application;

[0029] Fig.10 This is a bar chart comparing the time it takes rats to enter the open arms in the elevated plus maze experiment in Experimental Example 3 of this application;

[0030] Fig.11This is a bar chart comparing the immobility time of rats in the forced swimming test in Experimental Example 3 of this application;

[0031] Fig.12 This is a bar graph comparing the tail suspension static time of rats in the tail suspension experiment in Experimental Example 3 of this application;

[0032] Fig.13 This is a bar chart comparing the latency of rats to locate and cruise in the Morris water maze test in Experimental Example 3 of this application;

[0033] Fig.14 This is a bar chart comparing the number of times rats crossed the platform in the Morris water maze test in Experimental Example 3 of this application;

[0034] Fig.15 This is a bar chart comparing the residence time of rats in the Morris water maze test in Experimental Example 3 of this application;

[0035] Fig.16 This is a bar chart comparing the serum corticosterone content of rats in Experimental Example 3 of this application;

[0036] Fig.17 This is a bar chart comparing the content of adrenocorticotropic hormone in rat serum in Experimental Example 3 of this application;

[0037] Fig.18 This is a bar graph comparing dopamine content in rat hippocampal tissue in Experimental Example 3 of this application;

[0038] Fig.19 This is a bar chart comparison of norepinephrine content in rat hippocampal tissue in Experimental Example 3 of this application;

[0039] Fig. 20 This is a bar chart comparing the 5-hydroxytryptamine content in rat hippocampal tissue in Experimental Example 3 of this application;

[0040] Fig.21 This is a bar chart comparing the interleukin-6 content in rat hippocampal tissue in Experimental Example 3 of this application;

[0041] Fig. 22 This is a bar chart comparing the interleukin-1β content in rat hippocampal tissue in Experimental Example 3 of this application;

[0042] Fig.23 This is a bar chart comparing the content of α-tumor necrosis factor in rat hippocampal tissue in Experimental Example 3 of this application;

[0043] Fig.24 This is a partial view of the guinea pig skin of the blank control, model group, and sample group in Experimental Example 4 of this application;

[0044] Fig.25 This is a partial view of the guinea pig skin in the model group and the sample group on the second day of Experimental Example 4 of this application;

[0045] Fig.26 This is a partial view of the guinea pig skin in the model group and the sample group on the 3rd day of Experimental Example 4 of this application;

[0046] Fig. 27 This is a microscopic photo of the normal repair effect group in Experimental Example 4 of this application;

[0047] Fig.28 This is a microscopic photograph of the repair efficacy model group in Experimental Example 4 of this application;

[0048] Fig.29 This is a microscopic photo of the sample group with a repair effect of 5% in Experimental Example 4 of this application;

[0049] Fig.30 This is a microscopic photo of the sample group with a repair effect of 2.5% in Experimental Example 4 of this application;

[0050] Fig.31 This is a micrograph of the sample group with a repairing effect of 1% in Experimental Example 4 of this application. DETAILED DESCRIPTION

[0051] The present invention will be described in detail below in conjunction with the accompanying drawings and specific embodiments. The embodiments, experimental examples and descriptions of the present invention are used to explain the present invention but are not intended to limit the present invention.

[0052] Lotus embryo can clear the heart and soothe the mind, connect the heart and kidney, and has anti-inflammatory, sedative, antioxidant, and central nervous system protection effects; Forsythia can clear away heat and detoxify, disperse nodules and reduce swelling, and has analgesic, antibacterial, anti-inflammatory, anti-nutrition, inhibit elastase activity and nerve protection effects; Cinnamon can replenish fire and assist yang, warm and unblock the meridians, and has analgesic, sedative, anti-inflammatory, antioxidant and antidepressant effects; Lophatherum gracile can clear away heat and relieve restlessness, and has analgesic, antioxidant, immunity regulating and neuron protection effects; Ophiopogon can nourish yin and promote fluid production, moisten the lungs and clear the heart, and has anti-inflammatory, antioxidant, immunity regulating, improve epidermal hydration capacity, regulate neurotransmitter balance, and promote nerve damage repair effects; Polygala tenuifolia can calm the mind and improve intelligence, connect the heart and kidney, and has sedative, antidepressant, inhibit nerve cell apoptosis, prevent nerve cell damage, and improve cognitive function.

[0053] "Suwen Linglan Secret Classic" records: "The heart is the official of the monarch, and the spirit comes out of it." In addition, "Suwen Wuzang Formation Theory" also expounds other attributes of "heart" in traditional Chinese medicine theory, such as "the heart is the combination of pulse, its glory is the color, and it is the master of the kidney. The lung is the combination of skin, its glory is the hair, and it is the master of the heart." This shows that the function of "heart" affects people's emotions and mental consciousness, as well as their faces, complexion, skin and hair. According to the theory of the nature and flavor of traditional Chinese medicine and the meridians, traditional Chinese medicines that enter the heart meridian often have the functions of nourishing the heart, calming the mind, generating blood, and unblocking the meridians, and have a positive effect on the human nervous system and circulatory system. In traditional Chinese medicine theory, there is also a saying of "replenishing the shape with the shape", so the traditional Chinese medicines that enter the heart meridian, such as lotus embryo, forsythia, cinnamon, light bamboo leaves, ophiopogon, and polygala, which have specific medicinal parts, are selected and matched according to the theory of traditional Chinese medicine to relieve emotions and anti-aging.

[0054] Embodiment 1:

[0055] A mood-relief anti-aging skin care composition comprises, by weight, 10-30 parts of lotus embryos, 10-30 parts of forsythia, 5-20 parts of cinnamon bark, 10-30 parts of loquat leaves, 5-20 parts of ophiopogon japonicus, and 5-20 parts of polygala tenuifolia.

[0056] Embodiment 2:

[0057] A mood-relief anti-aging skin care composition. Compared with Example 1, Example 2 differs in that the component ratios of the compositions are different. The composition comprises, by weight, 10-25 parts of lotus embryo, 14-25 parts of forsythia, 6-15 parts of cinnamon bark, 10-20 parts of loquat leaf, 5-15 parts of ophiopogon japonicus, and 8-20 parts of polygala tenuifolia.

[0058] Embodiment 3:

[0059] The raw material of the composition of this embodiment is a composition with the components in the ratio described in Example 1 or Example 2. The composition is prepared into a product by the following method:

[0060] S1 extraction: extracting the raw material of the composition twice to obtain two extracts, which are then combined and concentrated under reduced pressure;

[0061] S2 purification: The concentrated solution was statically adsorbed on the resin for 24 hours, loaded into a column, eluted with pure water and then with 70% ethanol aqueous solution, and the 70% ethanol elution fraction was collected and concentrated;

[0062] Preparation of S3: Mix the obtained concentrated solution according to 10% of the concentrated solution, 55% of butanediol, 4% of propylene glycol, 6% of glycerol and 25% of water, stir at 60° C. for 30 minutes, and filter with a 0.22 μm filter membrane to obtain a composite product.

[0063] In S1, the raw materials of the composition were added with 1600 L of 71% ethanol aqueous solution at a liquid-to-material ratio of 16:1, the pH was adjusted to 5.0 with glacial acetic acid, and the mixture was heated under reflux for 256 min to obtain a first extract; 1700 L of 75% ethanol aqueous solution was added to the medicinal residues of the composition at a liquid-to-material ratio of 17:1, the pH was adjusted to 8.6 with aqueous ammonia, and the mixture was heated under reflux for 263 min to obtain a second extract; the two extracts were combined, concentrated under reduced pressure, and the ratio of concentrated solution (L): medicinal material (kg) was 1:2 to obtain a concentrated solution.

[0064] In S2, the resin is D101 macroporous adsorption resin, and the adsorption is carried out according to the ratio of the raw material to the resin of 1:1.25 (kg / L). After static adsorption for 24 hours, the column is loaded and eluted with pure water first, with a flow rate of 1BV / h and an elution volume of 7BV; then eluted with 70% ethanol aqueous solution, with a flow rate of 1.4BV / h and an elution volume of 13BV. The 70% ethanol elution portion is collected and concentrated. The amount of concentrate (L): medicinal material (kg): 1:5.

[0065] Embodiment 4:

[0066] In this example, 10 kg of the composition raw material is prepared according to the composition ratio of each component described in Example 1 and the preparation method described in Example 3. The specific steps are as follows:

[0067] 10 kg of the raw material composition was added with 160 L of 71% ethanol aqueous solution, the pH was adjusted to 5.0 with glacial acetic acid, and heated under reflux for 256 min to obtain the first extract;

[0068] Add 170 L of 75% ethanol aqueous solution to the first extracted medicinal residue, adjust the pH to 8.6 with ammonia water, and heat under reflux for 263 min to obtain the second extract;

[0069] Combine the two extracts, concentrate under reduced pressure, and the ratio of concentrate (L): medicinal material (kg) is 1:2 to obtain 5L of concentrate;

[0070] The concentrate was added with 12.5LD101 macroporous adsorption resin, and after static adsorption for 24 hours, it was loaded into a column and eluted with pure water at a flow rate of 1BV / h and an elution volume of 7BV; then eluted with a 70% ethanol aqueous solution at a flow rate of 1.4BV / h and an elution volume of 13BV. The 70% ethanol elution portion was collected and concentrated to obtain 2L of concentrate;

[0071] Mix 10% of the concentrate, 55% of butanediol, 4% of propylene glycol, 6% of glycerol and 25% of water, stir at 60°C for 30 minutes, and filter with a 0.22 μm filter membrane to obtain 20 L of the composition product.

[0072] Experimental Example 1: Design of extraction, purification and formulation process of the composition

[0073] First acidic extraction

[0074] Taking alcohol-soluble extract as the investigation index, four process parameters including ethanol concentration, extraction time, liquid-to-solid ratio and pH were investigated. The factor level table was designed through single factor experiment. (Table 1)

[0075] Alcohol-soluble extract extraction rate (%) = total weight of ethanol-soluble substances in the extract (g) / weight of the extract (g) Table 1 Level table of factors in the first extraction process

[0076]

[0077] Table 2 Response surface design for the first extraction process

[0078]

[0079]

[0080] Table 3 Analysis of variance in response surface test for the first extraction process

[0081]

[0082] According to the analysis of Desigh-Expert8.0.6 software, A1 (ethanol concentration), B1 (extraction time), C1 (liquid-to-solid ratio), and D1 (pH) were fitted to obtain the regression equation:

[0083] Y=36.28+1.83A1+1.63B1+1.37C1+0.51D1-0.82A1B1-0.05A1C1+1.25A1D1+0 .5B1C1-1.62B1D1-0.45C1D1-6.08A12-2.92B12-3.06C12-1.7D12, R2=0.9486

[0084] According to the fitting equation, the optimal extraction process is predicted to be: ethanol concentration 71.34%, extraction time 4.27h, liquid-to-solid ratio 16.2:1, pH 5.02, and the predicted alcohol-soluble extract extraction rate is 36.7988%. According to the actual production requirements, the first extraction process is determined to be: ethanol concentration 71%, extraction time 256min, liquid-to-solid ratio 16:1, pH 5.0. After three experimental verifications, the alcohol-soluble extract extraction rate is 36.9% (RSD = 1.26%).

[0085] Second alkaline extraction

[0086] Taking alcohol-soluble extract as the investigation index, four process parameters including ethanol concentration, extraction time, liquid-to-solid ratio and pH were investigated. The factor level table was designed through single factor experiment. (Table 4)

[0087] Table 4 Second extraction process factor level table

[0088]

[0089] Table 5 Response surface design for the second extraction process

[0090]

[0091] Table 6 Analysis of variance in response surface experiment for the second extraction process

[0092]

[0093]

[0094] According to the analysis of Desigh-Expert8.0.6 software, A2 (ethanol concentration), B2 (extraction time), C2 (liquid-to-solid ratio), and D2 (pH) were fitted to obtain the regression equation:

[0095] Y=15.06+2.72A2+1.56B2+1.35C2+0.19D2-0.35A2B2-0.075A2C2+0.33A2D2-0 .25B2C2-0.27B2D2+0.43C2D2-2.83A22-1.74B22-1.9C22-1.39D22, R2=0.9750

[0096] According to the fitting equation, the optimal extraction process is predicted to be: ethanol concentration 74.6%, extraction time 4.37h, liquid-to-solid ratio 16.68:1, pH 8.57, and the predicted alcohol-soluble extract extraction rate is 16.2114%. According to the actual production requirements, the second extraction process is determined to be: ethanol concentration 75%, extraction time 263min, liquid-to-solid ratio 17:1, pH 8.6. After three experimental verifications, the alcohol-soluble extract extraction rate is 16.6% (RSD = 2.73%).

[0097] Purification process

[0098] (1) Dosage of D101 macroporous adsorption resin

[0099] A total of 10 kg of the composition was subjected to optimized process conditions: ① 71% ethanol concentration, 256 min extraction time, 16:1 liquid-to-solid ratio, pH 5.0; ② 75% ethanol concentration, 263 min extraction time, 17:1 liquid-to-solid ratio, pH 8.6; extraction was performed twice, the extracts were mixed, concentrated to 5 L, the pH was adjusted to neutral, and set aside.

[0100] The outflow components after macroporous resin adsorption were detected using three color developing agents: 10% acetic anhydride-concentrated sulfuric acid, potassium bismuth iodide, and 10% sulfuric acid-ethanol to determine the resin adsorption capacity.

[0101] Take 50, 100, 150, 200, 250, 300, 350, 400, 450, 500 mL of the extract concentrate, dilute to 500 mL with pure water, add 500 mL of D101 macroporous adsorption resin, statically adsorb for 24 hours, load the column, collect the effluent, and detect with three color developers. (Table 7)

[0102] The results showed that the extract concentrate and D101 macroporous adsorption resin can be completely adsorbed at a volume ratio of 2:5, and the effective ingredients have flowed out at 1:2. Therefore, the volume ratio of the extract concentrate and D101 macroporous adsorption resin of 2:5 was selected as the reference dosage of D101 macroporous resin. In actual production, in order to facilitate the calculation of the resin dosage, it was converted into a medicinal material resin ratio of 1:1.25, that is, 1.25L of D101 macroporous adsorption resin is required for 1kg of medicinal material composition.

[0103] Table 7 Color developer detection results

[0104]

[0105] Note: “-” represents no color development; “+” represents color development.

[0106] (2) D101 macroporous resin desorption process

[0107] Ⅰ Investigation of water elution volume

[0108] According to the ratio of medicinal materials to resin, the extract concentrate and resin were mixed evenly, and after static adsorption for 24 hours, the column was loaded and eluted with pure water at a flow rate of 1BV / h. The effluent was followed and detected with iodine solution, ninhydrin colorimetric solution, and α-naphthol concentrated sulfuric acid solution. The test results are shown in Table 8. When the water elution reached the 7th column volume, no water-soluble impurities flowed out, and the water elution volume was determined to be 7BV.

[0109] Table 8 Water elution fraction detection results

[0110]

[0111] Note: “-” represents no color development; “+” represents color development.

[0112] Ⅱ Investigation of ethanol elution concentration

[0113] A parallel experimental group was set up. After washing and removing impurities, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, and 90% ethanol aqueous solutions were used for elution, respectively. The elution volume was 5BV, and the flow rate was 1BV / h. The eluate was collected, concentrated, dried, and weighed. The total alkaloids, total triterpenes, total saponins, and total phenylethanol glycosides were detected by UV-visible spectrophotometry. The test results are shown in the attached figure Figure 1 shown.

[0114] When eluting with 10% ethanol, some effective ingredients have already flowed out. When eluting with 70% ethanol, most of the main effective ingredients can be eluted. As the ethanol concentration increases, fat-soluble impurities flow out with the eluent, resulting in a decrease in the content of effective ingredients in the extract. Therefore, 70% ethanol aqueous solution was selected as the eluent for desorption of macroporous resin.

[0115] Ⅲ Elution flow rate investigation

[0116] A parallel experimental group was set up. After washing and removing impurities, 5 BV was eluted with 70% ethanol aqueous solution. The flow rates were set to 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, and 2.0 BV / h, respectively. The eluate was collected, concentrated, dried, and weighed. The total alkaloids, total triterpenes, total saponins, and total phenylethanol glycosides were detected by UV-visible spectrophotometry. The test results are shown in the attached figure Figure 2 shown.

[0117] For macroporous adsorption resins, generally speaking, the slower the flow rate, the better the desorption effect. Figure 2 It can be seen that the content of total effective ingredients is higher at low flow rates, and as the flow rate increases, the content of total effective ingredients decreases, especially after 1.4BV / h, the downward trend is more obvious. Considering the problem that in actual production, although the desorption effect is good when the flow rate is too slow, the time cost is high, the elution flow rate is determined to be 1.4BV / h.

[0118] IV. Investigation of the amount of ethanol used for elution

[0119] A parallel experimental group was set up. After washing and removing impurities, elution was performed with 70% ethanol aqueous solution. The elution volumes were 5, 7, 9, 11, 13, 15, and 17 BV, respectively, and the flow rate was 1.4 BV / h. The eluate was collected, concentrated, dried, and weighed. The total alkaloids, total triterpenes, total saponins, and total phenylethanol glycosides were detected by UV-visible spectrophotometry. The test results are shown in the attached figure Figure 3 shown.

[0120] From the 5th to the 11th column volume, the content of total effective substances in the eluent increases continuously. After eluting to 13 column volumes, the content of total effective substances in the eluent is relatively stable, and due to the increase in impurity content, the content has a slight downward trend. At the same time, considering the cost issues in actual production, the elution volume of the eluent is determined to be 13BV.

[0121] Purification process of ⅤD101 macroporous adsorption resin

[0122] Adsorb according to the ratio of medicinal material composition to resin of 1:1.25 (kg / L). After static adsorption for 24 hours, load the column and first elute with pure water at a flow rate of 1BV / h and an elution volume of 7BV; then elute with 70% ethanol aqueous solution at a flow rate of 1.4BV / h and an elution volume of 13BV. Collect the 70% ethanol elution part, concentrate it and dry it.

[0123] Three verification experiments were carried out according to the above process. The average total active ingredient content was 413 mg / g (RSD=2.67%) based on the total content of the four active ingredients: total alkaloids, total triterpenes, total saponins, and total phenylethanoid glycosides.

[0124] Preparation process:

[0125] The transmittance indicates the percentage of the light flux passing through a transparent or translucent solution to its incident light flux. The main reasons affecting the transmittance are the absorption of light by the solute in the solution and the refraction of light by the suspended particles in the solution. When the concentration of the solute in the solution is the same, the transmittance at the same temperature reflects the amount of suspended particles in the solution. The lower the transmittance, the more suspended particles there are and the lower the clarity. Therefore, measuring the transmittance with a UV-visible spectrophotometer can indirectly reflect the clarity of the solution. By scanning the full wavelength range of 200 to 900 nm, it is finally determined that the detection wavelength of the transmittance is 410 nm, and the reference solution is the solvent used in the preparation.

[0126] Transmittance (%) = Tsample / Treference × 100%

[0127] Take 10 kg of the medicinal material composition, extract it according to the above extraction process, purify it according to the purification process, collect the elution part of D101 macroporous adsorption resin 70% ethanol aqueous solution, and concentrate it under reduced pressure to 2 L to make it a suspension containing 5 kg of the original medicinal material composition per 1 L, and set it aside.

[0128] (1) Investigation of the dosage of butanediol

[0129] Set up parallel experiments, take 10 mL of the above suspension, add 5 mL of propylene glycol and 5 mL of glycerol, then add 40, 45, 50, 55, and 60 mL of butanediol respectively, make up to 100 mL with pure water, stir at 60°C for 30 min, filter with 0.22 μm filter membrane, and measure the transmittance.

[0130] Table 9 Investigation of the dosage of butanediol

[0131]

[0132] (2) Investigation of propylene glycol dosage

[0133] Set up parallel experiments, take 10 mL of the above suspension, add 55 mL of butanediol and 5 mL of propylene glycol, then add 2, 3, 4, 5, and 6 mL of propylene glycol respectively, make up to 100 mL with pure water, stir at 60°C for 30 min, filter with 0.22 μm filter membrane, and measure the transmittance.

[0134] Table 10 Propylene glycol dosage

[0135]

[0136] (3) Investigation of propylene glycol dosage

[0137] Set up parallel experiments, take 10 mL of the above suspension, add 55 mL of butanediol and 4 mL of propylene glycol, then add 2, 3, 4, 5, and 6 mL of propylene glycol respectively, make up to 100 mL with pure water, stir at 60°C for 30 min, filter with 0.22 μm filter membrane, and measure the transmittance.

[0138] Table 11 Investigation of propylene glycol dosage

[0139]

[0140] (4) Orthogonal experiment to optimize solvent dosage

[0141] Table 12 Orthogonal factor level table

[0142]

[0143] Table 13 Orthogonal experimental design

[0144]

[0145] Table 14 Analysis of variance

[0146]

[0147] * represents P < 0.05, indicating that the factor has a significant impact.

[0148] It can be seen from Tables 13 and 14 that the addition amount of the three solvents has a significant effect on the clarity of the solution (P < 0.05), and the effect size is: butanediol > propylene glycol > glycerol. According to the experimental results, 55 mL of butanediol, 4 mL of propylene glycol, and 6 mL of glycerol were selected as the best preparation combination.

[0149] Take 10 mL of the above suspension, add 55 mL of butanediol, 4 mL of propylene glycol, and 6 mL of glycerol, dilute to 100 mL with pure water, stir at 60°C for 30 min, filter with a 0.22 μm filter membrane, and measure the transmittance. Repeat the verification three times, and the average transmittance is 57.4% (RSD = 0.79%). The solution is a light brown clear transparent liquid when observed with the naked eye.

[0150] (5) Stability investigation

[0151] Ⅰ Temperature stability

[0152] Prepare the stock solution according to the above preparation method, set up parallel groups, dilute with water 10 times, 20 times, and 100 times, and set up 6 groups of the same dilution multiple. Put groups 1-3 in a 60℃ oven, and groups 4-6 in a -4℃ refrigerator, and continue to observe the changes in sample clarity.

[0153] Table 15 Clarity Observation Results

[0154]

[0155] Note: “-” means no turbidity and the sample remains clear; “+” means turbidity.

[0156] The experimental results show that the original solution and diluted samples can remain clear within 24 weeks at -4℃ and 60℃, and have good stability.

[0157] Ⅱ pH stability

[0158] Prepare the stock solution according to the above preparation method, set up parallel experiments, dilute 20 times with water, adjust the pH with acetic acid and sodium hydroxide aqueous solution, and make the solution pH 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, 10.0, 10.5, 11.0, 11.5, 12.0, 12.5, 13.0, 13.5, 14.0. Set up 6 groups of replicates for the same pH sample. Put groups 1-3 in a 60℃ oven and groups 4-6 in a -4℃ refrigerator, and observe the changes in sample clarity for 3 consecutive days.

[0159] Table 16 Effect of pH on Clarity (1)

[0160]

[0161] Note: “-” means no turbidity and the sample remains clear; “+” means turbidity.

[0162] Table 17 Effect of pH on Clarity (2)

[0163]

[0164] Note: “-” means no turbidity and the sample remains clear; “+” means turbidity.

[0165] The experimental results show that the sample can remain clear and stable between pH 3.5 and 9.5.

[0166] The preparation method of the mood-relief anti-aging skin care composition in this experimental example is divided into three process steps: extraction, purification, and preparation. The preparation process is shown in the attached figure. Figure 4 As shown, its preparation method is summarized as follows:

[0167] Extraction process:

[0168] The first extraction process was: ethanol concentration 71%, extraction time 256 min, liquid-to-solid ratio 16:1, pH 5.0;

[0169] The second extraction process was as follows: ethanol concentration 75%, extraction time 263 min, liquid-to-solid ratio 17:1, pH 8.6;

[0170] Combine the two extracts, concentrate under reduced pressure, and the ratio of concentrate (L): medicinal material (kg) is 1:2.

[0171] Purification process

[0172] Adsorb according to the ratio of medicinal material to resin of 1:1.25 (kg / L). After static adsorption for 24 hours, load on the column and first elute with pure water at a flow rate of 1BV / h and an elution volume of 7BV; then elute with 70% ethanol aqueous solution at a flow rate of 1.4BV / h and an elution volume of 13BV. Collect the 70% ethanol elution portion and concentrate it. The volume of concentrate (L): medicinal material (kg): 1:5.

[0173] Preparation process

[0174] Take the concentrated liquid obtained in the "purification process", mix it according to 10% of the concentrated liquid, 55% of butylene glycol, 4% of propylene glycol, 6% of glycerol, and 25% of water, stir it at 60°C for 30 minutes, and filter it with a 0.22μm filter membrane to obtain the mood-relief anti-aging skin care composition product of the present application.

[0175] Experimental Example 2: Human Safety Evaluation Experiment

[0176] According to the Technical Specifications for Safety of Cosmetics (2015 edition), human skin patch tests are used to evaluate human safety.

[0177] According to the subject inclusion criteria, 30 subjects were selected to participate in the test. Qualified spot test equipment with an area not exceeding 50mm2 and a depth of about 1mm was selected. The composition product prepared in Example 4 of the present application was diluted with pure water to 1%, 5%, and 10% of the sample to be tested, and pure water was used as a negative control. 0.025mL of each was put into the small chamber of the spot tester. The spot tester with the test substance was applied to the back of the subject with a low-allergenic tape, and gently pressed with the palm of the hand to evenly apply it to the skin for 24 hours. After removing the test substance spot tester, observe the skin reaction according to the standards in Table 18 30 minutes, 24 hours, and 48 hours after the indentation disappears, and record the observation results.

[0178] (Table 19)

[0179] Table 18 Skin reaction grading standards for skin occlusive patch test

[0180]

[0181] Table 19 Human patch test results

[0182]

[0183] The human patch test results showed the skin reactions of 30 test subjects at different times. None of the 30 people showed adverse reactions, indicating that this product is harmless and safe to the skin.

[0184] Experimental Example 3: Neuroprotective Effect Experiment

[0185] Experimental animals: SPF grade SD male rats, weighing 200g±10g, 6 weeks old. Rearing conditions: temperature 20-22°C, humidity (50±5)%, natural light, rats free access to food and water during the rearing period.

[0186] Experimental modeling: The classic depression model, chronic unpredictable mild stress (CUMS), was used for modeling. Rats were divided into a normal group and a model group. The model group was subjected to chronic unpredictable mild stimulation, including horizontal shaking for 5 minutes, 45° tilted cage, fasting for 24 hours, water deprivation for 24 hours, tail clamping for 5 minutes, 45°C oven heating for 5 minutes, and 6°C cold water swimming for 5 minutes. One stimulus was randomly given every day, combined with solitary housing. The modeling lasted for 28 days, and each stimulus was implemented 4 times. The sugar water preference experiment was used to verify the success of the modeling.

[0187] Grouping and administration: The animal experiment was divided into a normal control group, a blank control group, a fluoxetine control group, and low, medium, and high dose experimental groups. There were 5 rats in each group. The normal control group was not given any medication, the fluoxetine control group was given by gavage, and the blank control group and experimental group were given transdermal medication. The transdermal administration method was to select a fixed area of ​​the rat's back skin and remove 9 cm of the skin with a depilatory agent before administration. 2Wash the skin surface and check the skin integrity after 24 hours of normal feeding before applying the medicine.

[0188] Dosage: blank control was smeared with distilled water 10 ml / (kg·d); fluoxetine control group was gavaged with fluoxetine solution 20 mg / (kg·d); low-dose experimental group (SAM-L) was smeared with 1% sample diluent 10 ml / (kg·d), medium-dose experimental group (SAM-M) was smeared with 5% sample diluent 10 ml / (kg·d), high-dose experimental group (SAM-H) was smeared with 10% sample diluent 10 ml / (kg·d); the experimental group samples were the composition products prepared in Example 4 of the present application.

[0189] (1) Sugar water preference experiment

[0190] Day 1 of the training period: All animals were housed in individual cages, and each rat was given two bottles of liquid: two bottles of sucrose water (1%). During this period, the rats were allowed to eat and drink sugar water freely, and the position of the water bottle was changed every 12 hours.

[0191] On the second day of the training period: the two bottles of liquid for each rat were replaced: 1 bottle of sucrose water (1%) + 1 bottle of pure water. During this period, the rats were allowed to eat and drink freely, and the position of the water bottle was changed every 12 hours.

[0192] The day after the training period: remove the food and water bottles, and fast the animals for 24 hours. After the fasting period ends, conduct a sugar water preference test. Each rat freely drinks the sugar water and pure water weighed in advance for a total of 1 hour, and the laboratory environment must be kept quiet during the test. Remove all sugar water bottles and pure water bottles after 1 hour. Weigh the water bottles and calculate the animal's sugar water preference index (sugar water consumption / total liquid consumption × 100%). After the test, immediately give the animals food and water, and all rats are free to eat and drink.

[0193] The sugar water preference index is an important indicator for judging the degree of anhedonia and depression in rats. An increase in the index indicates that the degree of depression in rats is reduced.

[0194] The experimental record results are shown in the attached figure Figure 5 As shown, the preference for sugar water in depression model rats was significantly reduced when not administered, the fluoxetine positive control group could significantly increase the rats' preference for sugar water, and samples of different concentrations showed a dose-dependent increase in the rats' preference for sugar water. The high-dose group increased the rats' preference for sugar water better than the fluoxetine positive control group (P < 0.05), which was close to the normal group, and there was no significant difference.

[0195] (2) Mine experiment

[0196] Keep the experimental environment quiet and place the rats on a plate with a bottom area of ​​1m 2In a 50cm high mine reaction box, the detection system was used to record and analyze the movement of rats. The detection time was 5min.

[0197] The rats' depression was determined by recording their total distance and speed. When the normal rats were in a new environment, they would explore the environment. The depressed rat model tended to stay still. The changes in the total distance and speed of the rats' movements could show the degree of depression in the drug-treated rats.

[0198] The experimental record results are shown in the attached figure Figure 6 , Figure 7 As shown in the experimental results, the total distance and average speed of the rats in the blank control group were significantly lower than those in the normal rats (P < 0.05). Both the fluoxetine group and the sample group were able to improve these two indicators, but the overall level was lower than that of the normal rats, and it was significant (P < 0.05). It is speculated that the main reason is that both fluoxetine and the sample have a certain sedative effect, which will cause normal rats to tend to be still. However, compared with the model group, it can significantly increase the total distance and average speed of the depressed rats (P < 0.05).

[0199] (3) Novel environment inhibits food intake experiment

[0200] The rats were fasted and deprived of water for 24 hours in advance, and then placed in a corner of a square open box facing the box wall (the device is the same as the mine experiment). Before each test, 3 food pellets were placed in different positions near the center of the open box. The time from the rat being placed in the test box to the rat biting the food for the first time was recorded as the food ingestion latency. The total test time was 15 minutes. The open box should be cleaned before the next group of rats are tested.

[0201] The experimental record results are shown in the attached figure Figure 8 As shown in the results, a sudden change in living environment will have a certain impact on rats' food intake and increase the latency of rats' food intake. The latency of rats' food intake in the depression model was significantly prolonged (P < 0.05). Both the fluoxetine group and the sample group could significantly shorten the latency of rats' food intake in depression. The high-dose group and the fluoxetine group had similar effects on rats with depression, with no significant difference.

[0202] (4) Elevated plus maze test

[0203] The rats were placed in the experimental environment for 3 hours to adapt. After adaptation, the rats were placed in the center of the elevated plus maze with their heads facing the open arms. The experimental time was 5 minutes, and the number of entries and duration of the open and closed arms were recorded. At the end of each group of experiments, the entire elevated plus maze was cleaned up.

[0204] Open arm entry ratio = open arm entry / (open arm entry + open arm entry) × 100%

[0205] Open arm time ratio = open arm time / total time × 100%

[0206] The experimental record results are shown in the attached figure Fig. 9 , Fig.10 As shown in the figure, the number of times and duration that rats enter the open arm can reflect the rats' desire to actively explore the maze. The ratio of the number of times rats in the blank control group enter the open arm and the ratio of the time they enter the open arm are significantly lower than those of normal rats (P < 0.05). Both the fluoxetine group and the sample group can significantly increase the model rats' desire to explore the maze (P < 0.05). The fluoxetine group and the medium and high dose groups of the sample can reach the level of normal mice, and there is no significant difference.

[0207] (5) Forced swimming test

[0208] Pure water was added to a cylindrical transparent plastic bucket with a diameter of 25 cm and a height of 50 cm, so that the liquid level was kept at 35 cm from the bottom of the bucket and the temperature was maintained at 25 ± 1 ° C. The rats were placed in the experimental environment to adapt for 3 h, and then placed in the water. The movement of the rats was recorded with a camera. The experimental time lasted for 6 min, and the swimming time and immobility time of the rats in the water within 4 min were counted.

[0209] The experimental record results are shown in the attached figure Fig.11 As shown, the immobility time of depressed rats in water was significantly higher than that of normal rats (P < 0.05). Both the fluoxetine group and the sample group could reduce the immobility time of depressed rats in water, and the medium and high dose groups of the sample were better than the fluoxetine group. The immobility time of the high dose sample rats was similar to that of the normal rats, with no significant difference.

[0210] (6) Tail suspension test

[0211] Prepare a cylindrical opaque plastic box (50cm×30cm×30cm) with a tail holder in advance, with one side open for easy observation and recording. Place the rat in the experimental environment to adapt for 3 hours. After adaptation, tie the rat's tail to the holder, hang it upside down, and record its activities with a camera. The experiment lasts for 6 minutes, and the resting time of the rat within 4 minutes is counted. When the rat keeps its head in a neutral position for 2 seconds, start recording the resting time. When the rat moves again, pause the recording until it remains resting again. Finally, record the total resting time, that is, the resting time of the rat's tail suspension (s).

[0212] The experimental record results are shown in the attached figure Fig.12 As shown, the tail suspension immobility time of depressed rats was significantly prolonged compared with that of normal rats (P < 0.05). Both the fluoxetine group and the sample group could reduce the tail suspension immobility time of rats, and there was a significant difference compared with the blank group (P < 0.05).

[0213] (7) Morris water maze test

[0214] On the 1st to 5th day, the circular platform was placed in the Morris water maze, and the rats in each group were lowered from the position far away from the circular platform quadrant. The time to swim to the platform was recorded as the escape latency. If the platform was not found for more than 2 minutes, the rat was placed on the platform for about 30 seconds, once a day. From the 6th day, the spatial exploration test was carried out, the platform in the water maze was removed, and the number of times the rat crossed the original platform position and the length of stay within 2 minutes were recorded.

[0215] The experimental record results are shown in the attached figure Fig.13 , Fig.14 , Fig.15 As shown in the data, the latency time for the depressed rat model to find the platform in the water maze was significantly prolonged compared with that of normal rats (P < 0.05); when the platform was removed from the water, the number of times the rats crossed the platform and the time they stayed there were significantly reduced (P < 0.05), indicating that depression has a negative impact on the learning and memory abilities of rats.

[0216] Both the fluoxetine group and the sample group can reduce the latency of rats to find the platform in the water. Compared with the blank group, the fluoxetine group and the low-dose sample group were not significantly different, while the medium- and high-dose sample groups were significantly different from the blank group (P < 0.05). The latency of the high-dose group to find the platform was close to that of normal rats, and the difference was not significant.

[0217] After the platform was removed, the fluoxetine group and the sample group were able to increase the number of times the rats crossed the original platform position and the duration of stay. Compared with the blank group, the fluoxetine increase was not significant, and the low, medium and high dose groups of the sample were significantly different from the blank group (P < 0.05). The high dose group was close to normal rats, and the difference was not significant.

[0218] This indicates that although fluoxetine has an antidepressant effect, it has no significant effect on improving the learning and memory abilities of depressed rats. The sample has a good improvement effect on the learning and memory abilities of depressed rats, and has a certain dose correlation, and can restore the learning and memory abilities of depressed rats to a level close to that of normal rats.

[0219] Physiological index detection

[0220] Ⅰ Sample collection

[0221] After the behavioral experiment, the rats were collected. After anesthesia, blood was collected from the artery. The rats were killed after blood collection, and the brain tissue was taken and the hippocampal tissue on both sides was peeled off. After the blood was left to stand at 4°C overnight, the serum was separated at 3500r / min, 10min, and 4°C and stored in centrifuge tubes. The rat brain tissue and hippocampal tissue were stored in EP tubes. After the samples were collected, they were uniformly transferred to a -80°C refrigerator for storage.

[0222] Ⅱ Detection

[0223] ELISA kits were used to detect the levels of corticosterone and adrenocorticotropic hormone in rat serum, and the levels of inflammatory factors IL-6, IL1β, TNF-α, 5-HT, DA, and NE in rat serum and hippocampal tissue.

[0224] Take brain tissue homogenate, incubate at 37℃ for 5min, add o-nitrobenzene-β-D-galactoside solution, mix well, continue to incubate at 37℃ for 5min, add 3ml sodium bicarbonate solution, mix well, and let stand at room temperature. First add sodium bicarbonate solution to the blank control solution, and then add o-nitrobenzene-β-D-galactoside solution. Read the absorbance of brain tissue homogenate and blank control solution at 420nm on UV spectrophotometer, and substituting the difference into the standard curve to calculate the concentration of β-D-galactosidase.

[0225] The results of biochemical index determination are shown in the attached figure Figure 16-23 As shown in the figure, it can be seen that the levels of corticosterone, adrenocorticotropic hormone, dopamine, norepinephrine, 5-hydroxytryptamine, interleukin-6, interleukin-1β, and α-tumor necrosis factor in the serum and hippocampal tissue of depressed rats are significantly different from those of normal rats. Both the fluoxetine group and the sample group can effectively improve the levels of the above physiological factors, reduce the levels of corticosterone and adrenocorticotropic hormone, increase the levels of neurotransmitters dopamine, norepinephrine, and 5-hydroxytryptamine, and reduce the levels of neuroinflammatory factors interleukin-6, interleukin-1β, and α-tumor necrosis factor, and there are significant differences with the blank control group. The high-dose group can improve the levels of the above physiological factors to levels similar to those of normal rats.

[0226] In summary, in this experimental example, after experimental verification, the mood-relief anti-aging skin care composition showed a certain antidepressant effect in the rat sugar water preference test, open field test, novel environment inhibition of food intake test, elevated plus maze test, forced swimming test, tail suspension test and Morris water maze test, and at the same time had a good improvement effect on the learning and memory ability of depressed rats. Its pharmacology of regulating mood and relieving psychological stress has been verified through experiments.

[0227] Experimental Example 4: Skin Function Evaluation Experiment

[0228] (1) Evaluation of soothing effect

[0229] Guinea pigs were used as experimental animals, and a normal skin control group, a model group, and a smear sample group were set up. The smear sample of the sample group was the composition product prepared in Example 4 of the present application. Hair was removed from both sides of the spine of the guinea pig back (2×2 cm) 2Box. : Apply 0.5% 8-methoxypsoralen solution evenly on the back skin of the animal. One hour after application, put the animal into the phototoxic machine for 20 minutes of mixed UVA and UVB light. After overnight illumination, observe the skin condition. If it reaches moderate-severe state, the model is successfully established. If the skin reaction is not achieved, the modeling steps can be repeated once more. Each time the medicine is applied, the hair must be shaved before operation. The sample group is evenly given 5% sample 5mL, once a day, for a total of 5 days. Observe the skin reaction of the application site 24 hours after each sample. Calculate the average score of each animal in the control group and the experimental group every day according to the following formula.

[0230] Average score of each animal per day = (total score of erythema and edema / number of experimental animals) / number of experimental days

[0231] Table 20 Skin redness and swelling score

[0232]

[0233] Record the blank control, model group, and sample group guinea pig skin as shown in the attached figure Fig.24 As shown, the skin of guinea pigs in the model group and the sample group on the second day of use is recorded as shown in the attached figure Fig.25 As shown, the guinea pig skin of the model group and the sample group on the 3rd day was used as shown in the attached figure Fig.26 shown.

[0234] The skin of the guinea pigs in the model group was obviously red and swollen, and the skin redness and swelling score was high. After applying the sample, the skin redness and swelling of the model guinea pigs was significantly reduced, and as the number of days of use increased, the skin redness and swelling symptoms were reduced faster than in the model group.

[0235] (2) Repair effect

[0236] Wild-type AB strain zebrafish were used as experimental animals, and the age of zebrafish was 3 days after fertilization. The tail fin of the zebrafish was removed with a scalpel to establish a zebrafish tail fin injury model. The model zebrafish were randomly assigned to a 6-well plate, with 15 tails in each well. The sample was given in water, and the sample was the composition product prepared in Example 4 of the present application. A normal control group and a model control group were also set up, with a capacity of 3mL per well. Incubate in the dark at 28°C for 48 hours. Ten zebrafish were randomly selected from each experimental group and photographed under a dissecting microscope. Advanced image processing software was used to analyze and collect data, and the zebrafish tail fin area (A) was analyzed. The repair efficacy of the sample was calculated according to the formula to determine whether it had a repair efficacy.

[0237] Repair effect (%) = (A 样品-A模型 ) / (A 正常 -A 模型 )×100%

[0238] The restoration diagrams of the normal group, model group, 5% sample group, 2.5% sample group, and 1% sample group are shown in the attached figure. Figure 27-31 As shown, the results showed that the tail fin area of ​​zebrafish in different concentration sample groups was significantly increased compared with the model control group (P < 0.05), and the repair rates were 47%, 23%, and 12%, respectively.

[0239] To sum up, in this experimental example, it has been experimentally verified that the mood-relief anti-aging skin care composition has the effects of antibacterial and anti-inflammatory, improving local blood circulation of the skin, reducing redness and swelling symptoms caused by infection and allergies, reducing active oxygen damage to the skin, regulating the water and oil balance of the skin, and promoting the repair effect of collagen formation in the skin function evaluation experiment.

[0240] The embodiments and experimental examples of the present application disclose the components, component ratios, preparation process, and pharmacological verification, human safety evaluation, and skin function evaluation of the mood-relief anti-aging skin care composition. Through the pharmacological verification, human safety evaluation, and skin function evaluation, it can be determined without any objection that the mood-relief anti-aging skin care composition of the present application has a high application value in the technical field of skin care products, and can be used as the main functional ingredient of toners, essences, creams, and facial masks.

[0241] Although preferred embodiments of the present invention have been described, additional changes and modifications may be made to these embodiments by those skilled in the art once the basic inventive concepts are known. Therefore, the present invention is intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention. Obviously, those skilled in the art may make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the present invention and its equivalents, the present invention is also intended to include these modifications and variations.

Claims

1. A mood-relief anti-aging skin care composition, Features: The composition comprises, by weight, 10-30 parts of lotus embryos, 10-30 parts of forsythia, 5-20 parts of cinnamon bark, 10-30 parts of lophatherum gracile, 5-20 parts of ophiopogon japonicus, and 5-20 parts of polygala tenuifolia.

2. The mood-relief anti-aging skin care composition according to claim 1, Features: The composition comprises, by weight, 10-25 parts of lotus embryo, 14-25 parts of forsythia, 6-15 parts of cinnamon bark, 10-20 parts of lophatherum gracile, 5-15 parts of ophiopogon japonicus and 8-20 parts of polygala tenuifolia.

3. A method for preparing the mood-relief anti-aging skin care composition according to any one of claims 1 to 2, comprising the following steps: S1 extraction: extracting the raw materials of the composition and concentrating under reduced pressure; S2 purification: The concentrated solution is statically adsorbed by resin, loaded into a column, eluted with pure water and then with ethanol-water solution, the ethanol elution portion is collected and concentrated; S3 preparation: The obtained concentrated solution was mixed with butanediol, propylene glycol, glycerol and water, stirred at 60° C. for 30 min, and filtered with a filter membrane to obtain a composite product.

4. The preparation method according to claim 3, Features: In the S1 extraction process, the composition raw material was added to a 71% ethanol aqueous solution at a liquid-to-solid ratio of 16:1, the pH was adjusted to 5.0 with glacial acetic acid, and heated under reflux for 256 minutes to obtain a first extract.

5. The preparation method according to claim 4, Features: In the S1 extraction process, for the medicinal residues extracted for the first time, 75% ethanol aqueous solution was added to the composite medicinal residues at a liquid-to-solid ratio of 17:1, the pH was adjusted to 8.6 with ammonia water, and heated to reflux for 263 minutes to obtain a second extract; the two extracts were combined and concentrated under reduced pressure to obtain a concentrated solution.

6. The preparation method according to claim 5, Features: The volume of concentrated liquid (L) and medicinal materials (kg) in the reduced pressure concentration is 1:

2.

7. The preparation method according to any one of claims 3 to 6, Features: In the S2 purification process, the resin is D101 macroporous adsorption resin, and the adsorption is carried out according to the ratio of the raw material to the resin of 1:1.25 (kg / L). After static adsorption for 24 hours, the column is loaded and eluted with pure water first, with a flow rate of 1BV / h and an elution volume of 7BV; then eluted with 70% ethanol aqueous solution, with a flow rate of 1.4BV / h and an elution volume of 13BV. The 70% ethanol elution portion is collected and concentrated, and the amount of concentrate (L): medicinal material (kg): 1:

5.

8. The preparation method according to claim 3, Features: In the S3 preparation process, the concentrate is 10%, butanediol is 55%, propylene glycol is 4%, glycerol is 6%, water is 25%, and the filter membrane is a 0.22 μm filter membrane.

9. Use of the composition according to any one of claims 1 to 2 or the composition prepared by the preparation method according to any one of claims 3 to 8 in the field of cosmetics.

10. The use according to claim 9, Features: The application includes at least any one of the following aspects: protecting the central and peripheral nervous systems, reducing anxiety and depression; reducing redness and swelling symptoms caused by skin infection and allergies; alleviating skin active oxygen damage, regulating skin water and oil balance, and promoting collagen formation.